Effrx

Website Links

Description

EffRx, Inc. is a drug delivery company that utilizes value-added drug delivery technologies to improve the performance of established pharmaceuticals. The Company applies its technologies to well established, proven compounds to develop reformulated products with reduced gastrointestinal side effects, better absorption, and faster onset of action. EffRx develops novel prescription and OTC pharmaceuticals at relatively low development cost and risk, shorter time to market and with premium pricing compared with generics. The Company exploits a number of drug delivery technologies, notably soluble effervescent formulations, granules for immediate dispersion, and fast-melt lozenges with an effervescent layer. These technologies are applied to established high volume drugs with large market potential in various therapeutic areas. The Company's lead products are focused on the treatment of osteoporosis, xerostomia (dry mouth), and pain. EffRx currently has an extensive pipeline of product candidates, with three products in active development. The most advanced product is effervescent alendronate for the treatment of osteoporosis, which is being developed and commercialized in partnership with Generics UK Limited, a division of Merck KGaA. Also in active development are a bi-layer tablet for the treatment of xerostomia and a product for pain. EffRx is also in partnership discussions for several other products.

Products & services

Similar companies nearby